VEGFR-1/NRP-1 TARGETING PEPTIDES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12672647

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

(LPR), that selectively target VEGFR-I and NRP-I expressing cells. Targeted molecules in accor-dance with the invention are useful in the treatment and detection of neovascular or angiogenic VEGF associated disorders, including but not limited to cancer, obesity, diabetes, asthma, arthritis, cirrhosis and ocular diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM210 WEST 7TH STREET AUSTIN TX 78701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arap, Wadih Houston, US 60 561
Cardó-Vila, Marina Houston, US 2 4
Ceneviva, Lacerda De Almeida Fabio Rio de Janeiro, BR 1 3
Giordano, Ricardo Sao Paulo, BR 1 3
Pasqualini, Renata Houston, US 84 1135
Valente, Ana Paula Rio de Janeiro, BR 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation